Enrollment has accelerated in the last quarter, reflecting enthusiasm for this novel treatment option Data to be presented at a scientific conference in early 2023 DARTMOUTH, Nova Scotia, & CAMBRIDGE, Mass.--(BUSINESS WIRE)--$IMV #DeliveryPlatform--IMV
TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRE: 0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affectin
TORONTO & DALLAS--(BUSINESS WIRE)--$PINK.V #AI--Perimeter Medical Imaging AI, Inc. (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) announced the commercial placement of its flagship Perimeter S-Series OCT system at a hospital that is part of a major national healthcar
Initiation of first clinical study of multivalent VBI-2901, designed to increase breadth of protection against COVID-19 and related coronaviruses Preclinical data support broadly reactive immunity of VBI-2901 against a panel of coronavirus variants in
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is one of five Canadian companies accepted into this year
RAHWAY, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its third-quarter 2022 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. ET on Thursday, Octo
Ventus to receive $70 million upfront, with potential additional milestones of up to $633 million plus potential royalty payments and R&D funding Collaboration combines Ventus’ lead NLRP3 inhibitor program with Novo Nordisk’s deep expertise acro
This phase 2 trial evaluates the safety, tolerability, and immunogenicity of Covigenix VAX-001-1b in healthy adults 18 years and older A total of 268 participants have been enrolled in the study at two sites in Burkina Faso, completing the single and
The Fertility Partners’ Chief Medical Officer Dr. Al Yuzpe, known as the grandfather of IVF, honored for lifetime of achievement HALIFAX, Nova Scotia--(BUSINESS WIRE)--Dr. Al Yuzpe, Chief Medical Officer for The Fertility Partners and a pioneer in repr
EDMONTON, Alberta--(BUSINESS WIRE)--BioAlberta announced the recipients of its 2022 Achievement Awards in recognition of the outstanding contributions of the individuals and companies whose innovation and achievements have contributed to the growing succe
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.